AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper'...

cafead

Administrator
Staff member
  • cafead   Nov 07, 2023 at 11:23: PM
via Only two months after the Federal Trade Commission (FTC) said it was eyeing a crackdown on "improper" patents listed at the FDA, the agency has filed a challenge against more than 100 patents in the agency's Orange Book.

article source